title: [Construction of hepatitis C virus-NS3 Th1 plasmid vaccine based on MHC class II-associated invariant chain peptide substitution].
authors.affiliation: Department of Transfusion, Lanzhou General Hospital, Lanzhou Command, Lanzhou, China. 6603gaoming@163.com
authors.forename: Ming
authors.initials: M
authors.lastname: Gao
authors.forename: Hai-ping
authors.initials: HP
authors.lastname: Wang
authors.forename: Yuan
authors.initials: Y
authors.lastname: Lu
authors.forename: Yong
authors.initials: Y
authors.lastname: Zhou
authors.forename: Yan-ning
authors.initials: YN
authors.lastname: Wang
authors.forename: Lin-sheng
authors.initials: LS
authors.lastname: Zhan
authors.forename: Qaun-li
authors.initials: QL
authors.lastname: Wang
mesh_terms: D000818:Animals; D000944:Antigens, Differentiation, B-Lymphocyte / Q000276:immunology*; D015870:Gene Expression; D016174:Hepacivirus / Q000276:immunology*; D000949:Histocompatibility Antigens Class II / Q000276:immunology*; D051379:Mice; D008807:Mice, Inbred BALB C; D018417:Th1 Cells / Q000276:immunology / Q000378:metabolism*; D014761:Viral Hepatitis Vaccines / Q000235:genetics* / Q000276:immunology
chemical_list: D000944:Antigens, Differentiation, B-Lymphocyte; D000949:Histocompatibility Antigens Class II; D014761:Viral Hepatitis Vaccines; C045084:invariant chain